Guide To EU Pharmaceutical Regulatory Law - 2011
Property LawBird & Bird
Kluwer Law
Data aparitiei: 10 Aug 2011
Nr pagini : 850
• obtaining a marketing authorisation;
• stages and standards for creating a product dossier;
• clinical trials;
• how and when an abridged procedure can be used;
• criteria for conditional marketing authorisations;
• generic products and ‘essential similarity’;
• paediatric use and the requisite additional trials;
• biologicals and ‘biosimilars’;
• homeopathic and herbal medicines;
• reporting procedures;
• pharmacovigilance;
• parallel trade;
• relevant competition law and intellectual property rights; and
• advertising.
In addition, national variation charts in many of the chapters illustrate eight major jurisdictions (Belgium, France, Germany, Italy, The Netherlands, Spain, Sweden, and the UK). Sample forms and URLs for the most important Directives are included. Pharmaceutical lawyers and regulatory advisers, both in-house and in private practice, will welcome this unique book. It offers immeasurable value for all who need to understand the process of bringing a medicinal product or medical device to market and the continuing rights and obligations.
Clientii au mai comandat:
Pe aceeasi tematica: Property Law
» Abonamente
» Admitere
» Asistenta sociala
» Asigurari
» Business
» Cereri si actiuni in justitie
» Coduri si legi comentate
» Comert-Finante-Banci
» Comunicare si relatii publice
» Concurenta
» --------------
» A.G.E.P.I.
» A.G.E.R.
» A.S.D.P.I.
» A.S.R.O.
» Academia Romana
» All
» Argessis
» ASAB
» ASE






